Drug-Drug Interaction Potential of Mavorixafor

Clinical trial NCT06914869 · COMPLETED

Trial details

NCT number: NCT06914869
Sponsor: X4 Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2025-02-18
Primary completion: 2025-05-19
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.